X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (4216) 4216
Journal Article (1260) 1260
Conference Proceeding (45) 45
Publication (40) 40
Book / eBook (4) 4
Book Chapter (3) 3
Paper (3) 3
Dissertation (2) 2
Book Review (1) 1
Newspaper Article (1) 1
Report (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (2072) 2072
physics (2051) 2051
electric communication technique (1785) 1785
pictorial communication, e.g. television (1653) 1653
calculating (1141) 1141
computing (1141) 1141
counting (1141) 1141
image data processing or generation, in general (923) 923
chemistry (885) 885
metallurgy (875) 875
basic electronic circuitry (787) 787
code conversion in general (763) 763
coding (763) 763
decoding (763) 763
human necessities (694) 694
organic chemistry (658) 658
hygiene (597) 597
medical or veterinary science (597) 597
performing operations (584) 584
transporting (584) 584
preparations for medical, dental, or toilet purposes (542) 542
information storage (541) 541
information storage based on relative movement between recordcarrier and transducer (537) 537
specific therapeutic activity of chemical compounds ormedicinal preparations (499) 499
heterocyclic compounds (404) 404
acyclic or carbocyclic compounds (384) 384
cinematography (325) 325
electrography (325) 325
holography (325) 325
photography (325) 325
humans (315) 315
general tagging of cross-sectional technologies spanning over several sections of the ipc (295) 295
general tagging of new technological developments (295) 295
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (295) 295
index medicus (274) 274
electrophotography (246) 246
magnetography (246) 246
basic electric elements (243) 243
male (242) 242
female (214) 214
mechanical engineering (207) 207
blasting (206) 206
heating (206) 206
lighting (206) 206
weapons (206) 206
technical subjects covered by former uspc (195) 195
electric digital data processing (185) 185
vehicles in general (172) 172
handling record carriers (163) 163
presentation of data (163) 163
recognition of data (163) 163
record carriers (163) 163
middle aged (162) 162
aged (144) 144
testing (144) 144
measuring (143) 143
animals (135) 135
transmission of digital information, e.g. telegraphiccommunication (130) 130
education (128) 128
advertising (126) 126
cryptography (126) 126
display (126) 126
seals (126) 126
compositions based thereon (121) 121
organic macromolecular compounds (121) 121
their preparation or chemical working-up (121) 121
technical subjects covered by former us classification (117) 117
technologies or applications for mitigation or adaptation againstclimate change (113) 113
electric solid state devices not otherwise provided for (111) 111
semiconductor devices (111) 111
adult (108) 108
arrangements or circuits for control of indicating devicesusing static means to present variable information (106) 106
compositions of macromolecular compounds (101) 101
transmission (97) 97
surgery (94) 94
optics (91) 91
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (86) 86
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (83) 83
hunting (79) 79
agriculture (78) 78
animal husbandry (78) 78
fishing (78) 78
forestry (78) 78
trapping (78) 78
use of inorganic or non-macromolecular organic substances ascompounding ingredients (78) 78
fixed constructions (73) 73
analysis (71) 71
optical elements, systems, or apparatus (69) 69
working of plastics (65) 65
working of substances in a plastic state, in general (65) 65
biocides, e.g. as disinfectants, as pesticides, as herbicides (64) 64
pest repellants or attractants (64) 64
plant growth regulators (64) 64
preservation of bodies of humans or animals or plants or partsthereof (64) 64
medicine & public health (62) 62
aged, 80 and over (61) 61
oncology (61) 61
engineering elements and units (60) 60
general measures for producing and maintaining effectivefunctioning of machines or installations (60) 60
mice (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5099) 5099
French (880) 880
German (732) 732
Japanese (390) 390
Chinese (328) 328
Portuguese (102) 102
Korean (58) 58
Danish (49) 49
Spanish (30) 30
Finnish (22) 22
Swedish (21) 21
Slovenian (17) 17
Norwegian (16) 16
Greek (10) 10
Hungarian (9) 9
Italian (7) 7
Polish (4) 4
Arabic (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2012, Volume 7, Issue 8, p. e43403
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 2019
We present a case of an 8-year-old boy suffering from sudden-onset severe chest pain and cardiogenic shock due to cardiac tamponade caused by erosion of a... 
Figulla flex II | erosion | cardiac tamponade
Journal Article
Nature, ISSN 0028-0836, 05/2010, Volume 465, Issue 7295, pp. 223 - 226
Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder characterized by degeneration of motor neurons of the primary... 
OPEN-ANGLE GLAUCOMA | COMPLEX | PROTEIN | GENE | MULTIDISCIPLINARY SCIENCES | EXPRESSION | NEMO | MYOSIN-VI | Amyotrophic Lateral Sclerosis - physiopathology | Humans | Middle Aged | Transcription Factor TFIIIA - genetics | Cytoplasm - metabolism | Male | NF-kappa B - metabolism | Cytoplasm - pathology | Transcription Factor TFIIIA - metabolism | Mutation, Missense - genetics | DNA-Binding Proteins - metabolism | Young Adult | Base Sequence | Aged, 80 and over | Adult | Female | Child | Superoxide Dismutase - metabolism | NF-kappa B - agonists | Amino Acid Sequence | NF-kappa B - antagonists & inhibitors | Amyotrophic Lateral Sclerosis - genetics | Japan | Mutant Proteins - genetics | Transcription Factor TFIIIA - chemistry | Exons - genetics | Mutant Proteins - metabolism | Mutation - genetics | Transcription Factor TFIIIA - analysis | Protein Transport | Amyotrophic Lateral Sclerosis - pathology | Asian Continental Ancestry Group | Pedigree | Mutant Proteins - chemistry | Adolescent | Amyotrophic Lateral Sclerosis - metabolism | Polymorphism, Single Nucleotide - genetics | Aged | Consanguinity | Superoxide Dismutase-1 | Mutant Proteins - analysis | Codon, Nonsense - genetics | Sequence Deletion - genetics | Cellular proteins | Gene mutations | Physiological aspects | Amyotrophic lateral sclerosis | Genetic aspects | Research | Health aspects | Risk factors | Haplotypes | Studies | Genes | Genetics | Amino acids | Mutation | Family medical history | Chromosomes | Apoptosis
Journal Article
Nature Genetics, ISSN 1061-4036, 05/2016, Volume 48, Issue 5, pp. 500 - 509
Journal Article
Pediatric Research, ISSN 0031-3998, 12/2017, Volume 82, Issue 6, pp. 890 - 891
Journal Article
Cancer Science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 991 - 1000
Expression of CD44, especially the variant isoforms (CD44v) of this major cancer stem cell marker, contributes to reactive oxygen species (ROS) defense through... 
sulfasalazine | CD44v | opisthorchiasis | redox status | cholangiocarcinoma | Redox status | Sulfasalazine | Opisthorchiasis | Cholangiocarcinoma | OXIDATIVE STRESS | PROTEIN | PROSPECTIVE IDENTIFICATION | DRUG-RESISTANCE | CANCER STEM-CELLS | CYSTINE | OPISTHORCHIS-VIVERRINI | ONCOLOGY | CYSTINE/GLUTAMATE ANTIPORTER | GROWTH | CARCINOMA | Cricetinae | Reactive Oxygen Species - metabolism | Oxidation-Reduction | Cell Survival | Cholangiocarcinoma - parasitology | Humans | Gene Expression Regulation, Neoplastic | Sulfasalazine - pharmacology | Cholangiocarcinoma - metabolism | Enzyme Activation - drug effects | Carcinogenesis | Hyaluronan Receptors - genetics | Autophagy - drug effects | Animals | MAP Kinase Signaling System - drug effects | Cholangiocarcinoma - drug therapy | Hyaluronan Receptors - metabolism | Cell Line, Tumor | Cholangiocarcinoma - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Cell Proliferation - drug effects | p38 Mitogen-Activated Protein Kinases - metabolism | Mutation | Fasciola hepatica - pathogenicity | Immunohistochemistry | Cysteine | Chemotherapy | Thiols | Laws, regulations and rules | Cell death | Liver | Stem cells | Transplantation | Cancer | Cell proliferation | Flow cytometry | Oxidative stress | Transformation | Senescence | Gemcitabine | Laboratories | Infections | Kinases | Cancer therapies | Autophagy | Proteins | Cell growth | CD44 antigen | Cell cycle | Glutathione | Gene expression | Bile duct | Studies | Higher education | Medical prognosis | Isoforms | Glutamic acid transporter | Apoptosis | Original
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article